This study provided important insights into new, real time, control measures at reducing larval, vector density [Macro Seek and Destroy (S&D) and blood parasite level [Micro S&D] in a malaria treated and suspected intervened population. Initially, this study employed a low-cost (< $1000) drone (DJI Phantom) for eco-geographically locating, water bodies including natural water bodies, irrigated rice paddies, cultivated swamps, ditches, ponds, and other geolocations, which are among the common breeding sites for Anopheles mosquitoes in Gulu district of Northern Uganda. Our hypothesis was that by integrating real time, scaled up, sentinel site, spectral signature, unmanned aerial vehicle (UAV) or drone imagery with satellite data using geospatial artificial intelligence [geo-AI] infused into an iOS application (app), a local, vector control officer could retrieve a ranked list of visually similar, breeding site, aquatic foci of An.gambiae s.l. arabiensis s.s. fuentsus s.s. mosquitoes, and their respective district-level, capture point, GPS indexed, centroid coordinates. We real time retrieved (hence, no lag time between seasonal, aquatic, Anopheles, larval habitat, mapping and treatment of foci) each georeferenced sentinel site signature which was subsequently archived in the drone dashboard spectral library using the smartphone app. Each georeferenced, UAV sensed, capture point was inspected using a mobile field team (i.e., trained local village residents led by a vector control officer) on the same day the habitats were geo-AI signature mapped, spatially forecasted and treated. A second hypothesis was that a real time, environmentally friendly, habitat alteration [i.e., Macro S&D] could reduce vector larval habitat density and blood parasite levels in treated and not suspected malaria patients at an entomological intervention site. A

Background Over 200 million individuals worldwide are infected with Schistosoma species, with over half of infections occurring in children. Many children experience first infections early in life and this impacts their growth and development; however praziquantel (PZQ), the drug used worldwide for the treatment of schistosomiasis, only has regulatory approval among adults and children over the age of four, although it is frequently used “off label” in endemic settings. Furthermore, pharmacokinetic/pharmacodynamics (PK/PD) evidence suggests the standard PZQ dose of 40 mg/kg is insufficient in preschool-aged children (PSAC). Our goal is to understand the best approaches to optimising the treatment of PSAC with intestinal schistosomiasis. Methods We will conduct a randomised, controlled phase II trial in a Schistosoma mansoni endemic region of Uganda and a Schistosoma japonicum endemic region of the Philippines. Six hundred children, 300 in each setting, aged 12–47 months with Schistosoma infection will be randomised in a 1:1:1:1 ratio to receive either (1) 40 mg/kg PZQ at baseline and placebo at 6 months, (2) 40 mg/kg PZQ at baseline and 40 mg/kg PZQ at 6 months, (3) 80 mg/kg PZQ at baseline and placebo at 6 months, or (4) 80 mg/kg PZQ at baseline and 80 mg/kg PZQ at 6 months. Following baseline treatment, children will be followed up for 12 months. The co-primary outcomes will be cure rate and egg reduction rate at 4 weeks. Secondary outcomes include drug efficacy assessed by novel antigenic endpoints at 4 weeks, actively collected adverse events and toxicity for 12 h post-treatment, morbidity and nutritional outcomes at 6 and 12 months, biomarkers of inflammation and environmental enteropathy and PZQ PK/PD parameters. Discussion The trial will provide valuable information on the safety and efficacy of the 80 mg/kg PZQ dose in PSAC, and on the impact of six-monthly versus annual treatment, in this vulnerable age group. Trial registration ClinicalTrials.gov NCT03640377. Registered on 21 Aug 2018.

Background Achieving elimination of trachoma as a public health problem in trichiasis-endemic districts requires a systematic approach to trichiasis case finding and outreach. Methods Programme monitoring data from seven countries for 2017–2019 were used to explore the efficiency of different community mobilisation approaches and uptake of trichiasis surgical services. Results Three countries (Ethiopia, Kenya and Mozambique) using broad-based community mobilisation strategies had large numbers of people presenting at outreach but only 2.9% of them had trichiasis, while in four countries (Nigeria, Tanzania, Uganda and Zambia) using house-to-house case finding, 37.5% of outreach attendees had trichiasis. Countries using house-to-house case finding have proportionally more women attending outreach compared with countries using broad-based mobilisation. Among trichiasis cases offered surgery 86% accepted, which was similar for men and women. Conclusions In these settings, house-to-house case finding appears to be a more effective and efficient approach to ensure that trichiasis cases, particularly in women, obtain access to surgical services.

Purpose: There are several settlements in the Northern and Western Regions of Uganda serving refugees from South Sudan and Democratic Republic of Congo (DRC), respectively. Trachoma prevalence surveys were conducted in a number of those settlements with the aim of determining whether interventions for trachoma are required. Methods: An evaluation unit (EU) was defined as all refugee settlements in one district. Crosssectional population-based trachoma prevalence survey methodologies designed to adhere to World Health Organization recommendations were deployed in 11 EUs to assess prevalence of trachomatous inflammation-follicular (TF) in 1-9-year-olds and trachomatous trichiasis (TT) unknown to the health system in ≥15-year-olds. Household-level water, sanitation and hygiene coverage was also assessed in study populations. Results: A total of 40,892 people were examined across 11 EUs between 2018 and 2020. The prevalence of TF in 1-9-year-olds was <5% in all EUs surveyed. The prevalence of trachomatous trichiasis (TT) unknown to the health system in ≥15-year-olds was <0.2% in 5 out of 11 EUs surveyed and ≥0.2% in the remaining 6 EUs. A high proportion of households had improved water sources, but a low proportion had improved latrines or quickly (within a 30-minute return journey) accessible water sources. Conclusions: Implementation of the antibiotic, facial cleanliness and environmental improvement components of the SAFE strategy is not needed for the purposes of trachoma's elimination as a public health problem in these refugee settlements; however, intervention with TT surgery is needed in six EUs. Since instability continues to drive displacement of people from South Sudan and DRC into Uganda, there is likely to be a high rate of new arrivals to the settlements over the coming years. These populations may therefore have trachoma surveillance needs that are distinct from the surrounding non-refugee communities.